PHI with Amyotrophic lateral sclerosis
How does this condition affect your private health insurance?
Amyotrophische Lateralsklerose (ALS) is a progressive neurodegenerative disease that relentlessly attacks nerve cells (motor neurons) in the brain and spinal cord, controlling voluntary muscle movement. As these motor neurons degenerate, they lose the ability to send signals to muscles, leading to muscle weakness, atrophy, and eventual paralysis. This impacts crucial functions like speaking, swallowing, breathing, and moving limbs. Sensory functions and cognitive abilities are often preserved. There is currently no cure for ALS, and treatments focus on managing symptoms and improving the patient's quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms typically develop gradually over weeks to months, often starting with subtle muscle weakness, twitching, or stiffness in one limb, before progressing to other areas.
Duration of Illness (Lifetime)
ALS is a chronic, progressive, and ultimately fatal disease. The average life expectancy after diagnosis is 2 to 5 years, though some individuals may live longer.
Cost of Treatment (Initial)
Initial diagnostic evaluations, specialist consultations, and early medication can range from several thousand to tens of thousands of dollars, depending on the healthcare system and necessary tests.
Cost of Treatment (Lifetime)
The lifetime cost of ALS care is substantial, often exceeding hundreds of thousands to over a million dollars, encompassing medications, assistive devices (e.g., wheelchairs, communication aids), home modifications, respiratory support, physical/occupational/speech therapy, and skilled nursing care.
Mortality Rate
The probability of death from ALS is nearly 100%, typically occurring within 2 to 5 years of diagnosis, primarily due to respiratory failure.
Risk of Secondary Damages
Very high. Secondary damages include severe muscle atrophy, paralysis, dysphagia (difficulty swallowing) leading to malnutrition, dysarthria (speech impairment), respiratory insufficiency, and significant psychological distress such as depression and anxiety.
Probability of Full Recovery
Extremely low, virtually 0%. ALS is a uniformly fatal disease with no known cure or effective treatment that can halt or reverse its progression.
Underlying Disease Risk
While ALS is primarily a neurological disorder, approximately 5-10% of cases are familial (genetic). There is also an increased risk of developing frontotemporal dementia (FTD) in a subset of ALS patients. Other underlying diseases are generally not direct causes but can coexist.